Antiretroviral potential of human tripartite motif-5 and related proteins.
about
TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activityRestriction of retroviral replication by APOBEC3G/F and TRIM5alphaIndependent evolution of an antiviral TRIMCyp in rhesus macaquesActive site remodeling switches HIV specificity of antiretroviral TRIMCypConformational Adaptation of Asian Macaque TRIMCyp Directs Lineage Specific Antiviral ActivityHIV-1 evades innate immune recognition through specific cofactor recruitmentIntrinsic cellular defenses against human immunodeficiency virusesAn evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene familyBirth, decay, and reconstruction of an ancient TRIMCyp gene fusion in primate genomesEvolution of a TRIM5-CypA splice isoform in old world monkeysCyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.FIV cross-species transmission: an evolutionary prospective.Proteasomal degradation of TRIM5alpha during retrovirus restrictionHuman TRIM gene expression in response to interferonsSimplification, Innateness, and the Absorption of Meaning from Context: How Novelty Arises from Gradual Network EvolutionStabilized human TRIM5α protects human T cells from HIV-1 infection.The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.Clathrin facilitates the morphogenesis of retrovirus particles.TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro.Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9.Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells.Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restrictionTRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid.Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infectionFunctional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alphaA Novel Entry/Uncoating Assay Reveals the Presence of at Least Two Species of Viral Capsids During Synchronized HIV-1 Infection.Antiretroviral activity of ancestral TRIM5alpha.Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species.Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure.Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency virusesHost restriction factors blocking retroviral replicationTRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.The control of viral infection by tripartite motif proteins and cyclophilin A.Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.Upregulation of TRIM5α gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5α genotype has no impact on virus acquisition or vaccination outcomeHeterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors
P2860
Q24301176-BFE668B5-BCE4-4538-B548-288A8A39A12DQ24630459-D7BC4A7D-8848-4D87-A39A-F7CA5DA43190Q24656091-4DC820DC-BE5A-4DF8-9C7E-3DFBD6C433E2Q27657485-79715A07-7E7B-486F-BE8B-C4536131CD6BQ27664241-A31B16D5-3F8D-4772-9455-653ABD409911Q27680544-267F5CC6-0A39-4E7D-BD33-55AF372D481BQ28659575-CF24B474-2473-482F-883A-6958D7B6D4F4Q28661395-D26DA3A0-2EDB-4D93-A727-8EAB491B7EA0Q28708860-2C1D96C3-F226-4FD2-808F-06CAA9F9CFF6Q28755216-B300C837-16BE-473E-BD9F-6F48B5A52F19Q30400372-5EFE520D-CFB8-4127-883B-E43E94302CF7Q30839843-601CDCF7-3D9B-42B5-9398-C3B277510BBFQ31147670-52AEE9D6-3ABD-4FCB-A1CF-B0161810BA01Q33337129-6C34DBF8-84B3-426F-96C2-07539432E457Q33418607-69EF6FE3-797A-4CAF-82D0-2DF456B29245Q33676605-402B33AC-9C25-4F97-AEC6-0DD7D6773047Q33724266-9507D2A1-3520-4E11-B85E-881393113CE8Q33802684-E182DB2B-FC2E-4424-A024-3E1B8DFE645BQ33954411-58963860-EE65-4548-8F7D-F8A02FF11C4AQ33990615-2F3DA23D-B068-4596-ABD8-593C60CE6056Q34147534-B246DB46-B602-4BE8-8B44-607AF392371FQ34412329-B5B754D3-4DE3-439E-8F36-417610C59437Q34624282-F5C2CD27-A190-4771-B030-D26B3FBB4C88Q35076765-8FCFA109-C298-4DE9-9F1F-76C5860E10F5Q35140243-C221F994-53BD-4890-8D41-395EA6E03A62Q35140352-A63C2BBF-84AE-4ED4-84CB-ECB4820F2E86Q35140364-E28E916E-8E49-455E-ABEE-B466E32087EBQ35635089-59577F18-972D-4CEC-A666-50947DC12564Q36088778-6AA78D90-4AEA-4411-BFA3-F6FABF246C01Q36150032-B80CEE90-95FC-4FE0-A137-4EC96F535BF1Q36483961-7DDD98B5-DA44-499C-9C98-D862AD0FB010Q36491115-3811C36B-CCC5-4160-9AFB-FA55F8BF5BA0Q36667917-88C7BD50-85FD-4428-802F-457E5A209746Q36667979-39BAF3D6-2DB9-43A3-A65B-D748340EB677Q36687748-A9822BD5-BFDE-4792-A15C-670024A6FFF6Q36760097-17267E57-5224-4341-B746-41F545DB9DDDQ36848296-10492CD0-71EB-4A1C-A9E0-637563D48556Q36974763-9805CD93-8C9B-43F1-90E5-5AEA0B4395C5Q37006696-6E5C3242-5BBC-4E67-87D3-946364522FA9Q37116045-A12BA823-E4D5-48E2-A54B-BABDC700C9F7
P2860
Antiretroviral potential of human tripartite motif-5 and related proteins.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antiretroviral potential of human tripartite motif-5 and related proteins.
@ast
Antiretroviral potential of human tripartite motif-5 and related proteins.
@en
Antiretroviral potential of human tripartite motif-5 and related proteins.
@nl
type
label
Antiretroviral potential of human tripartite motif-5 and related proteins.
@ast
Antiretroviral potential of human tripartite motif-5 and related proteins.
@en
Antiretroviral potential of human tripartite motif-5 and related proteins.
@nl
prefLabel
Antiretroviral potential of human tripartite motif-5 and related proteins.
@ast
Antiretroviral potential of human tripartite motif-5 and related proteins.
@en
Antiretroviral potential of human tripartite motif-5 and related proteins.
@nl
P2093
P1433
P1476
Antiretroviral potential of human tripartite motif-5 and related proteins.
@en
P2093
David Derse
David Perez-Caballero
Fengwen Zhang
Paul D Bieniasz
Theodora Hatziioannou
P304
P356
10.1016/J.VIROL.2006.05.035
P407
P577
2006-07-10T00:00:00Z